Early Placental Insufficiency Screening
NCT01348711 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 226
Last updated 2023-05-16
Summary
To assess the role of uterine artery and maternal serum PlGf and sflt-1 and their combination in screening for pre-eclampsia and small -for-gestational age (SGA) fetuses at 12-14 weeks of gestation
Conditions
- Pre-eclampsia
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
collaborator OTHER_GOV -
University Hospital, Tours
lead OTHER
Principal Investigators
-
Franck PERROTIN, MD-PHD · Univsersity Hospital of TOURS
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2011-02-28
- Completion
- 2011-05-31
Countries
- France
Study Locations
More Related Trials
-
First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction
NCT02879942 ·Status: COMPLETED
-
Screening for Preeclampsia With Various Markers in Low-risk Pregnancy Populations
NCT01649128 ·Status: COMPLETED
-
Interest of sFlt1/PlGF Ratio at Obstetric Emergencies
NCT04170660 ·Status: UNKNOWN
-
sFlt-1:PlGF Ratio in Diagnosing Superimposed Preeclampsia
NCT03441711 ·Status: COMPLETED
-
Screening for Intrapartum Fetal Compromise Using Placental Biomarkers
NCT07258329 ·Status: RECRUITING
-
First Trimester Screening for Preeclampsia and Intrauterine Growth RestrIction Using Three Dimensional Doppler Angiography
NCT03342014 ·Status: COMPLETED ·Phase: NA
-
PREPARE, Prematurity Reduction by Pre-eclampsia Care
NCT03073317 ·Status: COMPLETED ·Phase: NA
-
Impact of the sFlt-1/PlGF Ratio on Medical Decision-making and on Maternal and Neonatal Outcomes in Women Suspected of Preeclampsia
NCT06314555 ·Status: COMPLETED
-
Preeclampsia Ratio (sFlt-1/PlGF)
NCT03289611 ·Status: COMPLETED ·Phase: NA
-
sFlt-1:PlGF Ratio in Gestational Diabetes: PREDICTION (PREeclampsia in DIabetiC gestaTION) Study
NCT04877119 ·Status: UNKNOWN
-
Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During Pregnancy
NCT00930397 ·Status: COMPLETED
-
Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio
NCT06403722 ·Status: COMPLETED
-
Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening
NCT03067298 ·Status: COMPLETED
-
Placental Insufficiency Microcirculation Quantification by Ultrafast Doppler (MICRODOPPLER PLACENTA)
NCT03860103 ·Status: COMPLETED
-
Predictive Value of SFlt-1/PlGF Ratio for the Diagnosis of Cardiovascular Disorders in the Puerperium: Pilot Study
NCT06720857 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications
NCT00485784 ·Status: COMPLETED ·Phase: NA
-
Biomarkers and Preeclampsia Outcomes
NCT03801447 ·Status: COMPLETED
-
Study of Biological Determinants of Bleeding Postpartum
NCT02884804 ·Status: COMPLETED
-
Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers
NCT01729468 ·Status: COMPLETED ·Phase: PHASE4
-
Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia
NCT02286284 ·Status: TERMINATED ·Phase: PHASE2
-
Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia
NCT03188900 ·Status: COMPLETED
-
Autophagy/Apoptosis Balance in Placental Vascular Pathologies
NCT06779916 ·Status: RECRUITING
-
Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
NCT05023161 ·Status: RECRUITING
-
GROSS-HIST : Quantification of the Main Circulating Histones During Normal Pregnancy and Pregnancies With Placenta-mediated Complications
NCT04205383 ·Status: COMPLETED
-
Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia
NCT07084727 ·Status: RECRUITING ·Phase: NA